18439803|t|Acute effects of N-(2-propylpentanoyl)urea on hippocampal amino acid neurotransmitters in pilocarpine-induced seizure in rats.
18439803|a|The present study aimed to investigate the anticonvulsant activity as well as the effects on the level of hippocampal amino acid neurotransmitters (glutamate, aspartate, glycine and GABA) of N-(2-propylpentanoyl)urea (VPU) in comparison to its parent compound, valproic acid (VPA). VPU was more potent than VPA, exhibiting the median effective dose (ED(50)) of 49 mg/kg in protecting rats against pilocarpine-induced seizure whereas the corresponding value for VPA was 322 mg/kg. In vivo microdialysis demonstrated that an intraperitoneal administration of pilocarpine induced a pronounced increment of hippocampal glutamate and aspartate whereas no significant change was observed on the level of glycine and GABA. Pretreatment with either VPU (50 and 100 mg/kg) or VPA (300 and 600 mg/kg) completely abolished pilocarpine-evoked increases in extracellular glutamate and aspartate. In addition, a statistically significant reduction was also observed on the level of GABA and glycine but less than a drastic reduction of glutamate and aspartate level. Based on the finding that VPU and VPA could protect the animals against pilocarpine-induced seizure it is suggested that the reduction of inhibitory amino acid neurotransmitters was comparatively minor and offset by a pronounced reduction of glutamate and aspartate. Therefore, like VPA, the finding that VPU could drastically reduce pilocarpine-induced increases in glutamate and aspartate should account, at least partly, for its anticonvulsant activity observed in pilocarpine-induced seizure in experimental animals. Some other mechanism than those being reported herein should be further investigated.
18439803	17	42	N-(2-propylpentanoyl)urea	ChemicalEntity	C108761
18439803	90	101	pilocarpine	ChemicalEntity	D010862
18439803	110	117	seizure	DiseaseOrPhenotypicFeature	D012640
18439803	121	125	rats	OrganismTaxon	10116
18439803	275	284	glutamate	ChemicalEntity	D018698
18439803	286	295	aspartate	ChemicalEntity	D001224
18439803	297	304	glycine	ChemicalEntity	D005998
18439803	309	313	GABA	ChemicalEntity	D005680
18439803	318	343	N-(2-propylpentanoyl)urea	ChemicalEntity	C108761
18439803	345	348	VPU	ChemicalEntity	C108761
18439803	388	401	valproic acid	ChemicalEntity	D014635
18439803	403	406	VPA	ChemicalEntity	D014635
18439803	409	412	VPU	ChemicalEntity	C108761
18439803	434	437	VPA	ChemicalEntity	D014635
18439803	511	515	rats	OrganismTaxon	10116
18439803	524	535	pilocarpine	ChemicalEntity	D010862
18439803	544	551	seizure	DiseaseOrPhenotypicFeature	D012640
18439803	588	591	VPA	ChemicalEntity	D014635
18439803	684	695	pilocarpine	ChemicalEntity	D010862
18439803	742	751	glutamate	ChemicalEntity	D018698
18439803	756	765	aspartate	ChemicalEntity	D001224
18439803	825	832	glycine	ChemicalEntity	D005998
18439803	837	841	GABA	ChemicalEntity	D005680
18439803	868	871	VPU	ChemicalEntity	C108761
18439803	894	897	VPA	ChemicalEntity	D014635
18439803	939	950	pilocarpine	ChemicalEntity	D010862
18439803	985	994	glutamate	ChemicalEntity	D018698
18439803	999	1008	aspartate	ChemicalEntity	D001224
18439803	1095	1099	GABA	ChemicalEntity	D005680
18439803	1104	1111	glycine	ChemicalEntity	D005998
18439803	1149	1158	glutamate	ChemicalEntity	D018698
18439803	1163	1172	aspartate	ChemicalEntity	D001224
18439803	1206	1209	VPU	ChemicalEntity	C108761
18439803	1214	1217	VPA	ChemicalEntity	D014635
18439803	1252	1263	pilocarpine	ChemicalEntity	D010862
18439803	1272	1279	seizure	DiseaseOrPhenotypicFeature	D012640
18439803	1422	1431	glutamate	ChemicalEntity	D018698
18439803	1436	1445	aspartate	ChemicalEntity	D001224
18439803	1463	1466	VPA	ChemicalEntity	D014635
18439803	1485	1488	VPU	ChemicalEntity	C108761
18439803	1514	1525	pilocarpine	ChemicalEntity	D010862
18439803	1547	1556	glutamate	ChemicalEntity	D018698
18439803	1561	1570	aspartate	ChemicalEntity	D001224
18439803	1648	1659	pilocarpine	ChemicalEntity	D010862
18439803	1668	1675	seizure	DiseaseOrPhenotypicFeature	D012640
18439803	Negative_Correlation	D014635	D001224	Novel
18439803	Negative_Correlation	D014635	D018698	Novel
18439803	Negative_Correlation	D014635	D010862	Novel
18439803	Association	C108761	D005680	No
18439803	Association	C108761	D005998	No
18439803	Negative_Correlation	C108761	D001224	Novel
18439803	Negative_Correlation	C108761	D018698	Novel
18439803	Comparison	C108761	D014635	Novel
18439803	Negative_Correlation	C108761	D012640	Novel
18439803	Negative_Correlation	C108761	D010862	Novel
18439803	Negative_Correlation	D012640	D014635	Novel
18439803	Positive_Correlation	D010862	D001224	Novel
18439803	Positive_Correlation	D010862	D018698	Novel
18439803	Positive_Correlation	D010862	D012640	No